Jenn Pichardo, Author at CMSC Scholar

The 16th Annual Johns Hopkins Multiple Sclerosis Symposium Series – Baltimore

DESCRIPTIONJoin our panel of experts for an interactive, live CME-/CNE-certified workshop exploring multidisciplinary strategies to enhance the diagnosis and management of multiple sclerosis (MS) in the rapidly evolving treatment landscape. This event features distinct tracks for specialists and primary care providers. Topics will include early recognition and differential diagnosis, the latest insights from clinical trials …

Continue reading “The 16th Annual Johns Hopkins Multiple Sclerosis Symposium Series – Baltimore”

Essentials in Multiple Sclerosis Care: A Comprehensive Curriculum for MS Nurses – Chicago

Saturday, May 4, 2024 7:30 am – 1:00 pm Breakfast and Presentation The Oak Brook Marriott 1401 W 22nd St Oak Brook, IL 60523 Elmhurst Room Expert Faculty Colleen Harris, MN, NP, MSCN (Co-Chairperson)MS Clinic Nurse PractitionerUniversity of Calgary MS ClinicAlberta, Canada Amy Perrin Ross, APN, CNRN, MSCN (Local presenting faculty)Neuroscience ConsultantChicago, Illinois Patricia Bobryk, MHS, PT, MSCS, …

Continue reading “Essentials in Multiple Sclerosis Care: A Comprehensive Curriculum for MS Nurses – Chicago”

IJMSC: Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Performance in Adults With Multiple Sclerosis

Release Date: March 1, 2024 Valid for Credit through: March 1, 2025 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, pharmacists, researchers, and other health care providers involved in the study and management of patients …

Continue reading “IJMSC: Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Performance in Adults With Multiple Sclerosis”

A Clinician’s Guide to the 2021 MAGNIMS-CMSC-NAIMS Consensus Recommendations on the use of MRI in Patients with MS

Released On: December 31, 2023 Expires On: December 31, 2024 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC)and Catamount Medical Education. This activity is supported by an independent educational grant from Genentech, A Member of the Roche Group. Target Audience This activity is intended for neurologists, radiologists, primary care clinicians, …

Continue reading “A Clinician’s Guide to the 2021 MAGNIMS-CMSC-NAIMS Consensus Recommendations on the use of MRI in Patients with MS”

IJMSC: Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis

Release Date: January 1, 2024 Valid for Credit through: January 1, 2025 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, social workers, and other health care providers involved in the management of patients with multiple …

Continue reading “IJMSC: Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis”

Preventing Common Secondary Conditions in Advanced MS

Tues. Nov. 29, 2022 – A Focus on Urinary Tract Infections Wed. Feb. 22, 2023 – A Focus on Pressure Injuries Wed. April 26, 2023 – A Focus on Aspiration Pneumonia Tues. Nov. 29, 2022 – A Focus on Urinary Tract Infections Target Audience This activity has been designed to meet the educational needs of …

Continue reading “Preventing Common Secondary Conditions in Advanced MS”

IJMSC: Symptom Management Among Multiple Sclerosis Care Partners in Canada

Release Date: November 1, 2023 Valid for Credit through: November 1, 2024 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, social workers, and other health care providers involved in the management of patients with multiple …

Continue reading “IJMSC: Symptom Management Among Multiple Sclerosis Care Partners in Canada”

Updates in Cognition and Multiple Sclerosis: Expert Guidance on Management Across the Continuum of the Disease

1.5 Continuing Education Credits available for Physicians, Nurses, Pharmacists, and Psychologists RELEASE DATE: September 29, 2023 EXPIRATION DATE: September 29, 2024 The estimated time to complete the activity is 90 minutes. This activity is supported by an independent educational grant from Bristol Myers Squibb. This activity is jointly provided by The Consortium of Multiple Sclerosis …

Continue reading “Updates in Cognition and Multiple Sclerosis: Expert Guidance on Management Across the Continuum of the Disease”

IJMSC: Innovations in Multiple Sclerosis Care: The Impact of Artificial Intelligence via Machine Learning on Clinical Research and Decision Making

Release Date: September 1, 2023 Valid for Credit through: September 1, 2024 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS). …

Continue reading “IJMSC: Innovations in Multiple Sclerosis Care: The Impact of Artificial Intelligence via Machine Learning on Clinical Research and Decision Making”

Neuromyelitis Optica Spectrum Disorder: Updates on Diagnosis and Treatment Management

Valid: July 7, 2023 through July 6, 2024 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. Activity Description Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing, autoimmune disease of the central nervous system that is characterized by inflammation …

Continue reading “Neuromyelitis Optica Spectrum Disorder: Updates on Diagnosis and Treatment Management”